Endologix
Clinical trials sponsored by Endologix, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- 10-Year look at aneurysm device: will it hold up? Results expected May 2027 (estimated)
-
New bypass device tested in Real-World leg artery study
Disease control By invitation onlyThis study is following 450 people with long blockages in their leg arteries who are treated with the DETOUR System, a device that creates a bypass inside the artery. The goal is to see how well it works and how safe it is in everyday medical practice. Participants are chosen by …
Sponsor: Endologix • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New stent device aims to fix Hard-to-Treat aortic aneurysms
Disease control OngoingThis study is testing a new device called the ChEVAS System for people with complex abdominal aortic aneurysms (bulges in the main blood vessel near the kidneys). The device is placed inside the blood vessel using a catheter, avoiding open surgery. Only 13 people are enrolled, an…
Sponsor: Endologix • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
10-Year look at aneurysm device: will it hold up?
Knowledge-focused OngoingThis study follows 2000 people who received the AFX2 system, a device to repair abdominal aortic aneurysms. Researchers will track complications like rupture, need for further procedures, and death over 5 to 10 years. The goal is to see how well the device performs in real-world …
Sponsor: Endologix • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC